Allavena P - Search Results

1

The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.

Allavena P, Sica A, Garlanda C, Mantovani A. Allavena P, et al. Immunol Rev. 2008 Apr;222:155-61. doi: 10.1111/j.1600-065X.2008.00607.x. Immunol Rev. 2008. PMID: 18364000 Review.

2

In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma.

Apiranthitou-Drogari M, Paganin C, Bernasconi S, Losa G, Maneo A, Colombo N, Mantovani A, Allavena P. Apiranthitou-Drogari M, et al. Among authors: allavena p. Cancer Immunol Immunother. 1992;35(4):289-95. doi: 10.1007/BF01789337. Cancer Immunol Immunother. 1992. PMID: 1387344 Free PMC article.

3

Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy.

Colombo N, Peccatori F, Paganin C, Bini S, Brandely M, Mangioni C, Mantovani A, Allavena P. Colombo N, et al. Among authors: allavena p. Int J Cancer. 1992 Apr 22;51(1):42-6. doi: 10.1002/ijc.2910510109. Int J Cancer. 1992. PMID: 1563843

4

Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium.

Allavena P, Paganin C, Martin-Padura I, Peri G, Gaboli M, Dejana E, Marchisio PC, Mantovani A. Allavena P, et al. J Exp Med. 1991 Feb 1;173(2):439-48. doi: 10.1084/jem.173.2.439. J Exp Med. 1991. PMID: 1671081 Free PMC article.

5

Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cells.

Biondi A, Paganin C, Rossi V, Benvestito S, Perlmutter RM, Mantovani A, Allavena P. Biondi A, et al. Among authors: allavena p. Eur J Immunol. 1991 Mar;21(3):843-6. doi: 10.1002/eji.1830210348. Eur J Immunol. 1991. PMID: 1826268

6

In vitro and in vivo effects of cisplatin on the generation of lymphokine-activated killer cells.

Allavena P, Pirovano P, Bonazzi C, Colombo N, Mantovani A, D'Incalci M. Allavena P, et al. J Natl Cancer Inst. 1990 Jan 17;82(2):139-42. doi: 10.1093/jnci/82.2.139. J Natl Cancer Inst. 1990. PMID: 2294223

7

Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cells.

Allavena P, Peccatori F, Maggioni D, Pirovano P, Mantovani A. Allavena P, et al. Immunopharmacol Immunotoxicol. 1989;11(2-3):257-68. doi: 10.3109/08923978909005369. Immunopharmacol Immunotoxicol. 1989. PMID: 2621319

8

Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells.

Bassan R, Pronesti M, Buzzetti M, Allavena P, Rambaldi A, Mantovani A, Barbui T. Bassan R, et al. Among authors: allavena p. Cancer. 1989 Jan 1;63(1):90-5. doi: 10.1002/1097-0142(19890101)63:1<90::aid-cncr2820630115>3.0.co;2-f. Cancer. 1989. PMID: 2783378

9

Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia.

Erroi A, Specchia G, Liso V, Colotta F, Bersani L, Polentarutti N, Chen ZG, Allavena P, Mantovani A. Erroi A, et al. Among authors: allavena p. Eur J Haematol. 1989 Jan;42(1):16-23. doi: 10.1111/j.1600-0609.1989.tb00241.x. Eur J Haematol. 1989. PMID: 2783672

10

Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents.

Allavena P, Damia G, Colombo T, Maggioni D, D'Incalci M, Mantovani A. Allavena P, et al. Cell Immunol. 1989 Apr 15;120(1):250-8. doi: 10.1016/0008-8749(89)90192-5. Cell Immunol. 1989. PMID: 2784721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters